ISIN | LU1871077506 |
---|---|
Valor Number | 43375930 |
Bloomberg Global ID | CSEQEDB LX |
Fund Name | UBS (Lux) Fund Solutions II - UBS MSCI Europe Index Fund EUR I-B acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | Equity Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Subfund tracks the MSCI Europe Index as its benchmark index. The Investment Objective of the Subfund is to provide the Shareholders with a return in line with the performance of the MSCI Europe Index (the “Underlying Index”) (see description under the section “Description of the Underlying Index”). |
Peculiarities |
Current Price * | 1,961.35 EUR | 21.08.2025 |
---|---|---|
Previous Price * | 1,961.79 EUR | 20.08.2025 |
52 Week High * | 1,961.79 EUR | 20.08.2025 |
52 Week Low * | 1,626.43 EUR | 09.04.2025 |
NAV * | 1,961.35 EUR | 21.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 121,645,827 | |
Unit/Share Assets *** | 99,465,839 | |
Trading Information SIX |
YTD Performance | +12.65% |
31.12.2024 - 21.08.2025
31.12.2024 21.08.2025 |
---|---|---|
YTD Performance (in CHF) | +12.45% |
31.12.2024 - 21.08.2025
31.12.2024 21.08.2025 |
1 month | +2.53% |
21.07.2025 - 21.08.2025
21.07.2025 21.08.2025 |
3 months | +1.32% |
21.05.2025 - 21.08.2025
21.05.2025 21.08.2025 |
6 months | +2.82% |
21.02.2025 - 21.08.2025
21.02.2025 21.08.2025 |
1 year | +11.58% |
21.08.2024 - 21.08.2025
21.08.2024 21.08.2025 |
2 years | +31.34% |
21.08.2023 - 21.08.2025
21.08.2023 21.08.2025 |
3 years | +40.42% |
22.08.2022 - 21.08.2025
22.08.2022 21.08.2025 |
5 years | +78.36% |
21.08.2020 - 21.08.2025
21.08.2020 21.08.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.51% | |
---|---|---|
Nestle SA | 2.34% | |
ASML Holding NV | 2.18% | |
Roche Holding AG | 1.93% | |
Novartis AG Registered Shares | 1.88% | |
AstraZeneca PLC | 1.86% | |
Novo Nordisk AS Class B | 1.80% | |
HSBC Holdings PLC | 1.68% | |
Shell PLC | 1.68% | |
Siemens AG | 1.45% | |
Last data update | 30.04.2025 |
TER | 0.02% |
---|---|
TER date | 31.12.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.02% |
Ongoing Charges *** | 0.02% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |